Alternance - Market Access (H/F)
Alexion Pharmaceuticals, Inc.Ile-de-France, France
Posted March 18, 2025
Internship
About the Company
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
Job Description
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines.
Requirements
- Analyses de prix, remboursement et benchmarking
- Participation au développement de dossiers d'accès au marché en France, BeLux
- Participation au développement de modèles économiques
- Évaluation de risques et opportunités
- Veille concurrentielle, environnementale et règlementaire des politiques de santé
Benefits
- Paid internship (Alternance)
